‘We Need Help,’ Says EMA Chief Amid COVID-19 & Burgeoning Workload

 
• By Ian Schofield
  
Generate a summary of this article
Listen to this article
Beta

COVID-19, resource constraints and a forthcoming expansion of its responsibilities are piling the pressure on the EU regulator.  

Credit squeeze concept - piggy bank in clamp
The EMA's financial and staff resources are under pressure • Source: Alamy

The executive director of the European Medicines Agency has made a plea for more staff and financial resources to help the agency face the challenges posed not only by COVID-19 but also by other work such as dealing with access to document requests and publishing clinical trial data – not to mention the proposed expansion of the organization's mandate as part of EU plans for a “European Health Union.”

“We need help. We definitely need help,” Emer Cooke told a 30 November hearing of the European Parliament’s environment and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

EU Biosimilar Filings, Opinions And Approvals

 
• By Saba Afreen

<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

EU Pharma Reform: What You Need to Know Now

 
• By Anabel Costa-Ferreira and Ian Schofield

As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

New EU Approvals

<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description